Back to search results

OPTIC Trial: Improving Pain and Opioid Treatment in Indigenous Communities

This study, called the Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial, is looking at ways to improve how chronic pain and opioid misuse (using opioids in a way that is harmful) or opioid use disorder (addiction to opioids) are addressed in American Indian and Alaska Native communities. Researchers are testing a culturally-focused approach to screening (checking for these conditions) and brief intervention (short, focused support) in clinics. You might be able to join if you are 18 or older, identify as American Indian/Alaska Native, have chronic pain and/or opioid misuse/opioid use disorder, and receive services at one of the participating clinics. The study aims to see how many clients are screened for these conditions at 6 months.

Study design
This is an interventional study planning to enroll 225 participants. It is testing a behavioral intervention focused on culturally-centered screening and brief intervention.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study measures outcomes at 6 months (or duration of implementation phase) and again at 6 months (or duration of sustainment phase).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06565416

Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial

Recruiting
NAAges 18+InterventionalTreatment
University of New Mexico
~225 participants
Updated 2025-11-12 on ClinicalTrials.gov
What's tested:Implementation Strategies

At a glance

Recruiting sites
1 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of clients screened for chronic pain and opioid misuse/opioid use disorder
Measured over 6 months (or duration of implementation phase)
+1 more outcome measured

Conditions

Opioid Use Disorder
Opioid Misuse
Chronic Pain

Explore related trials

Chronic PainOpioid MisuseOpioid Use Disorder

Where it's being run

3 sites across 3 states
California1
Minnesota1
Washington1

Study leadership

  • Matthew R Pearson, PhD · PRINCIPAL_INVESTIGATOR · University of New Mexico

Who to contact

Kamilla L Venner, PhD
[email protected]
5059252300
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Willing and able to provide informed consent
have English comprehension and proficiency
receiving services at one of our participating study sites
report current chronic pain and/or opioid misuse/opioid use disorder
self-identify as American Indian/Alaska Native

Exclusion

if they have a psychiatric, cognitive, or medical condition that interferes with the consenting process

What this trial measures

  • Number of clients screened for chronic pain and opioid misuse/opioid use disorder6 months (or duration of implementation phase)

    Derived from electronic medical records

  • Number of clients screened for chronic pain and opioid misuse/opioid use disorder6 months (or duration of sustainment phase)

    Derived from electronic medical records